Incannex Healthcare Ltd Share Price Today: Live Updates & Key Insights

Incannex Healthcare Ltd share price today is $2.9852, up -3.55%. The stock opened at $3.05 against the previous close of $3.1, with an intraday high of $3.05 and low of $2.86.

Incannex Healthcare Ltd Share Price Chart

Incannex Healthcare Ltd

us-stock
To Invest in {{usstockname}}
us-stock

Incannex Healthcare Ltd Share Price Performance

$2.9852 -0.0355(-3.55%) IXHL at 23 Mar 2026 01:44 PM Drug Manufacturers - Specialty & Generic
Lowest Today 2.86
Highest Today 3.05
Today’s Open 3.05
Prev. Close 3.1
52 Week High 49.80
52 Week Low 2.40
Day’s Range: Low 2.86 High 3.05
52-Week Range: Low 2.40 High 49.80
1 day return -
1 Week return -8.51
1 month return -63.32
3 month return +578.69
6 month return +478.06
1 year return +276.25
3 year return -61.01
5 year return -
10 year return -

Incannex Healthcare Ltd Institutional Holdings

Global X Marijuana Life Sciences ETF 0.77

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 0.77

Arete Wealth Advisors, LLC 0.62

Jane Street Group LLC 0.42

AdvisorShares Investments, LLC 0.18

Virtu Financial LLC 0.11

Commonwealth Equity Services Inc 0.10

LPL Financial Corp 0.09

Citigroup Inc 0.05

Advisor Group Holdings, Inc. 0.05

UBS Group AG 0.05

Fidelity Nasdaq Composite Index 0.03

Geode Capital Management, LLC 0.03

Morgan Stanley - Brokerage Accounts 0.02

XTX Topco Ltd 0.02

Axxcess Wealth Management, LLC 0.01

Victory Capital Management Inc. 0.01

TWO SIGMA SECURITIES, LLC 0.01

AdvisorShares Psychedelics ETF 0.01

Barclays PLC 0.01

NEW WAVE WEALTH ADVISORS LLC 0.00

Revisor Wealth Management LLC 0.00

Regal Investment Advisors LLC 0.00

Incannex Healthcare Ltd Market Status

Incannex Healthcare Ltd Fundamentals

Market Cap 41.78 M

PB Ratio 0.5692

PE Ratio 0.0

Enterprise Value -26.96 M

Total Assets 20.45 M

Volume 429406

Incannex Healthcare Ltd Company Financials

Annual Revenue FY25:86000 0.1M, FY24:12000 0.0M, FY23:0 0.0M, FY22:0 0.0M, FY21:1897596 1.9M

Annual Profit FY25:86000 0.1M, FY24:12000 0.0M, FY23:0 0.0M, FY22:-6338 -0.0M, FY21:985628 1.0M

Annual Net worth FY25:-46885000 -46.9M, FY24:-18459000 -18.5M, FY23:-19979558 -20.0M, FY22:-15025993 -15.0M, FY21:-8160911 -8.2M

Quarterly Revenue Q4/2025:0 0.0M, Q3/2025:0 0.0M, Q2/2025:66616 0.1M, Q1/2025:0 0.0M, Q4/2024:12000 0.0M

Quarterly Profit Q4/2025:null 0.0M, Q3/2025:null 0.0M, Q2/2025:66616 0.1M, Q1/2025:null 0.0M, Q4/2024:12000 0.0M

Quarterly Net worth Q4/2025:-6521000 -6.5M, Q3/2025:-6407000 -6.4M, Q2/2025:-35572000 -35.6M, Q1/2025:-6626917 -6.6M, Q4/2024:-5894000 -5.9M

About Incannex Healthcare Ltd & investment objective

Company Information Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research and development of psychedelic medicines and therapies for patients with chronic diseases in Australia. The company develops IHL-42X, an oral fixed dose combination of dronabinol and acetazolamide that is in Phase 2/3 clinical trial for the treatment of obstructive sleep apnea; and PSX-001, an oral synthetic psilocybin treatment in Phase 2b clinical development for patients with generalized anxiety disorder. It is also developing IHL-675A, an oral fixed dose combination drug containing synthetic cannabidiol and hydroxychloroquine sulphate to treat rheumatoid arthritis, as well as lung inflammation, acute respiratory disease, chronic obstructive pulmonary disease, asthma, bronchitis, inflammatory bowel disease, colitis, and Crohn's disease. Incannex Healthcare Inc. is headquartered in Sydney, Australia.

Organisation Drug Manufacturers - Specialty & Generic

Employees 12

Industry Drug Manufacturers - Specialty & Generic

CEO Mr. Joel Bradley Latham

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Incannex Healthcare Ltd FAQs

What is the share price of Incannex Healthcare Ltd today?

The current share price of Incannex Healthcare Ltd is $2.9852.

Can I buy Incannex Healthcare Ltd shares in India?

Yes, Indian investors can buy Incannex Healthcare Ltd shares by opening an international trading and demat account with Motilal Oswal.

How to buy Incannex Healthcare Ltd shares in India?

You can easily invest in Incannex Healthcare Ltd shares from India by:

Can I buy fractional shares of Incannex Healthcare Ltd?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Incannex Healthcare Ltd?

Incannex Healthcare Ltd has a market cap of $41.78 M.

In which sector does Incannex Healthcare Ltd belong?

Incannex Healthcare Ltd operates in the Drug Manufacturers - Specialty & Generic sector.

What documents are required to invest in Incannex Healthcare Ltd stocks?

To invest, you typically need:

What is the PE and PB ratio of Incannex Healthcare Ltd?

The PE ratio of Incannex Healthcare Ltd is N/A and the PB ratio is 0.57.